Andy AI

The pitch that matters here isn't the scribe. Ambient documentation is commoditized; every vendor has a record button. Andy's actual product is the pair of built-in QA and human-reviewed coding, and that's where an agency either saves money or doesn't. Pick Andy when OASIS documentation is the bottleneck. The reported numbers, roughly an hour saved per OASIS, coding inside 48 hours, and a 7% case-mix lift, are what you're underwriting. Case-mix is the one to price carefully: that figure is measured across agencies using Andy and the vendor itself says results vary by payer mix and starting point. Model the low end before you sign. The consistency checks are the quiet win. In practice, a hip replacement code sitting next to a documented incision is exactly the kind of mismatch that becomes a denial or a survey finding, and having it flagged at the note level beats catching it during a chart audit. We'd pass if home health isn't your actual business. Acute care, hospital systems, and private-pay home care without OASIS requirements get little from the PDGM logic. Same if you want to eliminate human review entirely from coding — a coder touches every chart here by design. Cost comparisons should be run per episode against whatever you pay for outsourced QA or coding today, since Andy positions itself under that line. There's no published tier list we can stand behind, so get a quote in writing and test it against one census before rolling out agency-wide. Closest alternatives depend on your EMR and your appetite for in-house QA; Andy has been running public comparisons against Nestmed, Olli Health, Enzo Health, Roger Healthcare, and broader home health scribe lists, which tells you the field is crowded. The differentiator worth defending is the coding review layer,